← SynDRA
PICTILISIB
SynDRA canonical compound SYN0014242 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PIK3CG |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
- PIK3CG
- PIK3CA
- PIK3CB
- PIK3CD
- PIK3R1
- PIK3R2
- PIK3R3
- PIK3R5
Mechanisms of action (all sources)
- PI3K inhibitor
- PIK3R1 INHIBITOR
- PIK3CB INHIBITOR
- PIK3CG INHIBITOR
- PIK3CA INHIBITOR
- PIK3R2 INHIBITOR
- PIK3CD INHIBITOR
- PIK3R5 INHIBITOR
- PIK3R3 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCC4
- AAK1
- PASK
- PIK3C2G
- PIK3C2B
- PIK3C2A
- PI4KB
- PI4KA
- PHKG2
- PHKG1
- PFKP
- PEBP1
- PDXK
- PDPK1
- PDGFRB
- PDGFRA
- PAK6
- PIM1
- PAK5
- PAK4
- PAK3
- PAK2
- PAK1
- PAICS
- OXSR1
- OPA1
- OLA1
- OGG1
- NUAK2
- NUAK1
- PIK3C3
- PIM2
- NTRK2
- PIM3
- PRKCI
- PRKCH
- PRKCE
- PRKCD
- PRKCB
- PRKCA
Cross-references
Synonyms
- PICTRELISIB
- RG-7321
- CDC-0941
- GDC-0941
- GDC0941
- PICTILISIB (GDC-0941)
- RG7321
- GDC 0941
- Pictrelisib
- 4-(2-(1H-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine
- 2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine
- UNII-ICY00EMP8P
- ICY00EMP8P
- Pictilisib (GDC-0941)
- CHEBI:65326
- AK-40872
- Thieno[3,2-d]pyrimidine, 2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)-
- GD9
- GDC-0941, GDC0941
- 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine
- pictilisibum
- RefChem:929266
- DTXCID70164421
- GDC-0941 (Pictilisib)
- C23H27N7O3S2
- MFCD11616196
- Pictilisib [USAN:INN]
- Kinome_3719
- PICTILISIB [MI]
- GDC0941(Pictilisib)
- PICTILISIB [INN]
- Pictilisib (USAN/INN)
- PICTILISIB [USAN]
- GDC0941(Pictilisib)?
- PICTILISIB [WHO-DD]
- MLS006010057
- SCHEMBL190812
- GTPL5682
- orb1306809
Look up PICTILISIB in the interactive SynDRA portal →